Synthetic and Systems Biology Unit, Biological Research Centre (BRC), Eötvös Loránd Research Network (ELKH), Temesvári körút 62, Szeged, 6726, Hungary.
Doctoral School of Interdisciplinary Medicine, University of Szeged, Korányi fasor 10, Szeged, 6720, Hungary.
Sci Rep. 2021 Jul 20;11(1):14813. doi: 10.1038/s41598-021-94217-1.
Recent statistics report that more than 3.7 million new cases of cancer occur in Europe yearly, and the disease accounts for approximately 20% of all deaths. High-throughput screening of cancer cell cultures has dominated the search for novel, effective anticancer therapies in the past decades. Recently, functional assays with patient-derived ex vivo 3D cell culture have gained importance for drug discovery and precision medicine. We recently evaluated the major advancements and needs for the 3D cell culture screening, and concluded that strictly standardized and robust sample preparation is the most desired development. Here we propose an artificial intelligence-guided low-cost 3D cell culture delivery system. It consists of a light microscope, a micromanipulator, a syringe pump, and a controller computer. The system performs morphology-based feature analysis on spheroids and can select uniform sized or shaped spheroids to transfer them between various sample holders. It can select the samples from standard sample holders, including Petri dishes and microwell plates, and then transfer them to a variety of holders up to 384 well plates. The device performs reliable semi- and fully automated spheroid transfer. This results in highly controlled experimental conditions and eliminates non-trivial side effects of sample variability that is a key aspect towards next-generation precision medicine.
最近的统计数据报告显示,欧洲每年有超过 370 万例新的癌症病例,该疾病约占所有死亡人数的 20%。在过去几十年中,高通量筛选癌细胞培养物一直主导着寻找新型有效抗癌疗法的研究。最近,基于患者来源的离体 3D 细胞培养的功能测定在药物发现和精准医学方面变得越来越重要。我们最近评估了 3D 细胞培养筛选的主要进展和需求,并得出结论,严格标准化和稳健的样品制备是最需要的发展方向。在这里,我们提出了一种人工智能引导的低成本 3D 细胞培养传递系统。它由一台显微镜、一个微操作器、一个注射器泵和一个控制器计算机组成。该系统对球体进行基于形态的特征分析,并可以选择均匀大小或形状的球体将它们在各种样品支架之间转移。它可以从标准样品支架(包括培养皿和微孔板)中选择样品,然后将它们转移到多达 384 孔板的各种支架中。该设备可以可靠地执行半自动和全自动球体转移。这可以实现高度可控的实验条件,并消除了由于样品变化带来的非平凡的副作用,这是迈向下一代精准医学的关键方面。